Blog
BrightInsight Raises Significant Capital to Enhance its Regulated Digital Health Platform and Accelerate Global Commercialization
Digital Health is an Opportunity for New Relationships Between Payers, Biopharma, and Medtech
Ambiguity Persists in FDA Regulation of Digital Combination Products
News
Avoid These Mistakes to Accelerate Digital Innovation within Big Biopharma and Medtech
BrightInsight Announces the Launch of a CE-marked Dosing Calculator for Emicizumab
Events
New York - BrightInsight Ecosystem Event 2020
The 2nd annual BrightInsight Ecosystem Event will bring together some of the industry's top minds to explore real-world digital health use cases, discuss best-practices for moving from pilot to scale and share how to accelerate digital innovation within biopharma and medtech companies.
San Mateo - Digital Therapeutics West
BrightInsight's CTO & Co-Founder, Ferry Tamtaro will be apart of the panel discussion: What's going to stop Digital Therapeutics from Breaking Big.
San Francisco - J.P. Morgan 38th Annual Healthcare
BrightInsight will be hosting our 3rd Annual Digital Health Panel at JP Morgan’s Healthcare Conference. This year's panel will dig deeper than what’s on the surface to understand how the world’s top biopharma and medtech companies are investing in digital, discuss how to partner with digital therapeutics and technology leaders and how to disrupt traditional organizations from within.